What GHK-Cu is
GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine, commonly abbreviated as GHK or written as Gly-His-Lys. The free peptide is a short chain of three amino acids joined by peptide bonds, and in the copper complex a single copper(II) ion is coordinated by the peptide to form a defined metal-peptide species. The two entities are catalogued separately: the free tripeptide GHK carries CAS number 49557-75-7, while the copper complex GHK-Cu carries CAS number 89030-95-5.
The complex is frequently described in the literature by its distinctive blue colouration, a property associated with copper(II) coordination compounds. This visible colour arises from d-d electronic transitions of the coordinated copper ion and is one of the more immediately observable characteristics distinguishing the complex from the colourless free peptide. In research contexts the compound is treated as a molecular tool for investigating copper-dependent biochemistry rather than as a finished product for any applied use.
Natural occurrence and age-related decline
GHK was first identified as a naturally occurring peptide present in human plasma. It has since been reported in other biological fluids, and the peptide is generally understood in the literature to arise from the breakdown of larger proteins, including collagen, releasing the tripeptide sequence that can then associate with copper ions available in the surrounding environment.
A recurring observation in the published literature is that the measured concentration of GHK in human plasma tends to decline with increasing age. This age-associated change has made the peptide a subject of interest for researchers examining how endogenous signalling molecules and copper handling shift over the lifespan. The decline is discussed as a descriptive finding within in-vitro and biochemical studies and should not be interpreted as implying any particular outcome in living systems.
The copper-binding chemistry
The defining feature of GHK-Cu is its ability to bind copper(II) with notable affinity. The histidine residue in the central position of the tripeptide provides an imidazole nitrogen that participates in metal coordination, alongside additional donor atoms from the peptide backbone and terminal groups. This arrangement produces a stable, well-characterised copper-peptide complex under physiologically relevant conditions.
Because of this coordination behaviour, GHK is often described in the literature as a copper-transport or copper-shuttling molecule. Research models have examined how the peptide may participate in moving copper between binding partners and how the presence or absence of the bound copper ion changes the properties studied in a given assay. Copper itself is an essential trace element that serves as a cofactor for numerous enzymes, which is one reason the copper-binding aspect of GHK attracts continued study.
ECM, collagen and fibroblast pathways in the literature
Much of the in-vitro research on GHK-Cu concerns the extracellular matrix (ECM), the network of proteins and other molecules that surrounds cells in tissue. Studies have used cultured cells and cell-free systems to examine how the complex interacts with processes involved in ECM remodelling, including the turnover and organisation of matrix components. This body of work is descriptive and mechanistic, focusing on signalling and molecular interactions observed under controlled laboratory conditions.
Fibroblasts, the connective-tissue cells that produce collagen and other matrix proteins, feature prominently in these investigations. Researchers have reported on GHK and GHK-Cu in the context of collagen-related signalling and fibroblast activity in cell-culture models. The literature frames these findings as observations within experimental systems, and they do not constitute evidence of any effect in whole organisms.
Beyond direct matrix interactions, GHK has been studied for its reported capacity to modulate gene expression in in-vitro models. Transcriptomic analyses in the published literature have described patterns of altered expression across broad sets of genes when cells are exposed to the peptide. These gene-expression studies are exploratory in nature and are used to generate hypotheses about the pathways the molecule may touch.
Molecular identity and characterisation
Clear molecular identity is central to reproducible peptide research. GHK-Cu is defined by its amino-acid sequence, glycine-histidine-lysine, together with the coordinated copper(II) ion, and by its two distinct CAS registrations for the free peptide and the complex. Analytical characterisation typically draws on techniques such as high-performance liquid chromatography (HPLC) to assess purity and mass spectrometry to confirm molecular mass and identity.
For copper-containing species, spectroscopic methods that report on the metal coordination environment are also relevant, and the characteristic blue colour offers an immediate qualitative indication that the copper is present in the expected form. Accurate documentation of sequence, mass, purity and copper content allows different laboratories to compare results on a consistent basis and to distinguish the intact complex from the free peptide or from degradation products.
How GHK-Cu is supplied for research
For laboratory use, GHK-Cu is generally supplied as a lyophilised (freeze-dried) solid. Lyophilisation removes water to give a dry material that is more stable during storage and transport and that can be reconstituted by the researcher in an appropriate solvent when required. As with other peptides, handling and storage conditions influence stability, and characterisation data accompanying a batch help establish its identity at the point of receipt.
Sova Peptides supplies GHK-Cu for research use with a batch-linked Certificate of Analysis, allowing the specific material received to be matched to its own analytical documentation. This reference article describes the compound's identity and the pathways studied in the scientific literature only; it does not describe how the material should be prepared, applied or used.
Research-use disclaimer
The information in this article is provided strictly for research and educational reference. GHK-Cu described here is intended for laboratory research use only. Nothing in this article constitutes dosing, administration, therapeutic, medical, cosmetic or other guidance for use in humans or animals, and no health, beauty or individual outcome is claimed or implied.
All statements refer to molecular identity, biochemistry and findings reported in in-vitro and laboratory literature. Researchers are responsible for complying with all applicable laws, regulations and institutional requirements governing the acquisition, handling and use of research materials in their jurisdiction.
Frequently asked
What is GHK-Cu?
GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine (Gly-His-Lys). It consists of the three-amino-acid peptide GHK coordinated to a single copper(II) ion, forming a defined metal-peptide species studied in research settings.
What is the difference between GHK and GHK-Cu?
GHK refers to the free tripeptide glycyl-L-histidyl-L-lysine, with CAS number 49557-75-7. GHK-Cu refers to the same peptide coordinated to a copper(II) ion, with CAS number 89030-95-5. The copper complex is the copper-bound form of the peptide.
Why is GHK-Cu blue?
The blue colour is associated with the coordinated copper(II) ion. It arises from d-d electronic transitions characteristic of copper(II) coordination compounds, which is why the copper complex is coloured while the free peptide is not.
Does GHK occur naturally?
GHK was first identified as a naturally occurring peptide in human plasma and has been reported in other biological fluids. It is generally understood in the literature to be released from the breakdown of larger proteins such as collagen.
Why is GHK associated with ageing in the literature?
Published studies report that the measured concentration of GHK in human plasma tends to decline with increasing age. This is a descriptive observation that has made the peptide a subject of interest for researchers, without implying any particular outcome.
What pathways is GHK-Cu studied for?
In-vitro research has examined GHK-Cu in the context of copper transport, extracellular-matrix (ECM) remodelling, collagen and fibroblast-related signalling, and modulation of gene expression in cell-culture and cell-free models. These are mechanistic laboratory observations only.
How is GHK-Cu characterised analytically?
Characterisation typically uses high-performance liquid chromatography (HPLC) to assess purity and mass spectrometry to confirm molecular mass and identity, alongside its defined sequence and CAS registration. The characteristic blue colour offers a qualitative indication of copper coordination.
How is GHK-Cu supplied for research?
It is generally supplied as a lyophilised (freeze-dried) solid for laboratory research use. Sova Peptides provides GHK-Cu with a batch-linked Certificate of Analysis so the specific material can be matched to its own analytical documentation.